77.00

Content Details
Information on this page was last modified on : 2021/05/17 6:07:04 PM

Clamoxin suspension DS 312.5 mg 60 mL

Clamoxin suspension DS contains Co-amoxiclav | belongs to Broad-spectrum penicillin

Alternate brands of Clamoxin suspension DS 312.5 mg 60 mL

Brand Name Price Savings
Zamoclav tablet 1 gm 6’s  157.22 You will pay -80.22 more
Zamoclav tablet 625 mg 10’s  198.80 You will pay -121.8 more
Zamoclav tablet 375 mg 10’s  138.62 You will pay -61.62 more
Zamoclav suspension 156.25 mg 60 mL  71.00 You can save 6
Zamoclav suspension 312.5 mg 60 mL  110.56 You will pay -33.56 more
List of alternate brands

How it works

Amoxycillin binds to certain specific receptors and prevents the formation of a necessary component for cell wall building process. Clavulanic acid is effective against a specific species of bacteria that are resistant to other antibiotic medicines. Thus, the combination becomes effective against an extended range of bacteria.

Side effects

Major & minor side effects for Clamoxin suspension DS 312.5 mg 60 mL

  • Allergic Skin Reaction severe
  • Diarrhea severe
  • Fever severe
  • Joint pain
  • Skin yellowing
  • Easy bruising and bleeding
  • Heavy menstrual bleeding
  • Tooth discoloration
  • Nausea or vomiting
  • Altered sense of taste
  • Convulsions severe
  • Painful intercourse severe
  • Swelling of face, lips, eyelids, tongue, hands and feet severe
  • Black or tarry stools
  • Muscle or joint pain
  • Sleeplessness
  • Irregular heartbeat

Uses of Clamoxin suspension DS 312.5 mg 60 mL

What is it prescribed for?

  • Nose Infection (Sinusitis)

    This medicine is used in the treatment of infections of the nose and nasal chamber caused by bacteria.

  • Lower Respiratory Tract Infection

    This medicine is used in the treatment of infections of the airways leading to the lungs. The infections can be Pneumonia, acute bronchitis, or others caused by different bacterial strains.

  • Ear Infection (Otitis Media)

    This medicine is used to treat infections of the middle ear caused by bacteria.

  • Throat Infection (Tonsillitis/Pharyngitis)

    This medicine is used in the treatment of infections of the throat and airways leading to lungs, namely Tonsillitis and Pharyngitis caused by bacteria.

  • Skin Infection

    This medicine is used in the treatment of infections of the skin and skin structures caused by bacteria.

  • Urinary Tract Infection

    This medicine is used in the treatment of infections of the bladder (Cystitis) and kidneys (Pyelonephritis).

  • Infections associated with surgical procedures

    This medicine is used to prevent possible infections associated with major surgical procedures such as joint replacement surgery, biliary tract surgery, etc.

  • Bone and Joint infections

    This medicine is used for the treatment of infections of the bones and joints (Osteomyelitis) caused by Staphylococcus aureus.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine can be observed within 1-2 hours of administration.

  • Duration of Effect

    The effect of this medicine lasts for an average duration of 6-8 hours.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit forming tendencies were reported.

  • Usage in pregnancy?

    This medicine should be used in pregnant women only if the need is clearly established and the benefits outweigh the risks. Consult your doctor before using this medicine.

  • Usage while breast-feeding?

    This medicine should be used in breastfeeding women only if the need is clearly established. Consult your doctor before using this medicine.

When not to use?

  • Allergy

    This medicine is not recommended for use if you have a known history of allergy to Amoxycillin or Clavulanic acid derivatives. Do not consume this medicine if you have a known history of allergy to Penicillins or Beta lactam antibiotics.

  • Cholestasis

    This medicine is not recommended for use if you have had a condition where the normal flow of bile from the liver is interrupted (cholestasis).

  • Liver dysfunction

    This medicine is not recommended for use if you have a history of liver dysfunction associated with the use of these medicines in combination.

Warnings

Warnings for special population
  • Pregnancy

    This medicine should be used in pregnant women only if the need is clearly established and the benefits outweigh the risks. Consult your doctor before using this medicine.

  • Breast-feeding

    This medicine should be used in breastfeeding women only if the need is clearly established. Consult your doctor before using this medicine.

General Warnings
  • Allergic Reaction

    This medicine is likely to cause moderate to severe allergic reaction and the likelihood is very high in patients who are known to have an antibiotic allergy. Report the occurrence of any such reaction to the doctor on priority.

  • Diarrhea

    Use of this medicine is likely to cause diarrhea. It may be a mild episode requiring no specific treatment or a severe case of colitis or Clostridium Difficile-Associated Diarrhea (CDAD). Chances of occurrence are very high in patients having a history of diarrhea after using antibiotics. All such instances should be reported to the doctor on priority.

  • Mononucleosis

    This medicine is not recommended for use in patients with Mononucleosis. This medicine is likely to cause rashes and bumps on the skin if the patient is suffering from Mononucleosis.

  • Drug-resistance

    Usage of this medicine without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of development of bacteria that are drug resistant.

  • Liver disease

    This medicine should be used with caution in patients having an impairment of the normal liver function. It is advised to regularly monitor the liver enzyme levels while taking this medicine and even after treatment with this medicine is complete.

  • Form and method of administration

    This medicine is generally administered either by slow intravenous injection over a period of 3-4 minutes or by intravenous infusion over a period of 30-40 minutes. It is not suitable for intramuscular administration. The patient should be shifted to oral forms as soon as possible.

Dosage

  • Missed Dose

    Since this medicine is administered in a hospital or clinical setup, the likelihood of missing a dose is very low. Contact your doctor immediately if you have missed a scheduled dose of this medicine.

  • Overdose

    Since this medicine is administered in a clinical or a hospital setup, the likelihood of an overdose is very low. However, if an overdose of this medicine is suspected, your doctor will initiate emergency medical treatment. Symptoms of an overdose may include nausea, vomiting, diarrhea, drowsiness, etc.

Interactions

Interaction with Medicines
  • Doxycycline moderate
  • Methotrexate severe
  • Warfarin moderate
  • Ethinyl Estradiol moderate
  • Live vaccines severe
Disease interactions
  • moderate

    This medicine is not recommended for use in patients with a history of mononucleosis since these patients may develop a skin reaction/eruption. Replacement with a suitable alternative should be done under your doctor's supervision.

  • moderate

    This medicine should be used with extreme caution in patients having a history of gastrointestinal diseases, particularly colitis. Inform your doctor if you have any history of gastrointestinal diseases. Report any incidence of severe diarrhea, abdominal pain, and blood in stools to the doctor immediately. Replacement with a suitable alternative may be necessary based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with a history of renal diseases or active renal diseases. Close monitoring of the renal function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases based on the clinical condition.

Food interactions
  • Urine Sugar Test (Benedict's of Fehling's reagent) moderate

    Report the use of this medicine prior to the test. This medicine may give a false positive result for the presence of glucose/sugar in the urine. The urine sugar test should be performed with a different reagent in case you are receiving this medicine.

General Instructions

Administer Clamoxin suspension DS 312.5 mg 60 mL as prescribed by the doctor. It is recommended to administer this medicine under the supervision of a doctor or a trained healthcare professional.

Other details

  • Usage does not depend on food timings
  • To be taken as instructed by doctor
  • Does not cause sleepiness

References

Additional Information:

How to use Clamoxin suspension DS 312.5 mg 60 mL

By direct IV push over a period of 3-4 min used within 20 min of reconstitution. By IV intermittent infusion over 30-40 min and complete within 4 hours of reconstitution.

what are the adverse effects of Clamoxin suspension DS 312.5 mg 60 mL?

Hepatitis, cholestatic jaundice, erythema multiforme (including Stevens-Johnson syndrome), toxic epidermal necrolysis, exfoliative dermatitis, vasculitis, rarely prolongation of bleeding time, dizziness, headache, convulsions (particularly with high doses or in renal impairment), superficial staining of teeth with suspension, phlebitis at injection site, hypersensitivity reactions, GI upset, blood dyscrasias, CNS effects, antibiotic associated colitis.

What happens if I miss a dose of Clamoxin suspension DS 312.5 mg 60 mL?

ORAL: Susp 156.25 mg: Children: Under 3 mth, not recommended; 3-9 mth, 2.5 mL half-strength; 9 mth-2 yr, 5 mL half-strength. 2-6 yr, 5 mL. All three times daily for up to fourteen days, then review.
Susp 312.5 mg: Children: 6-12 yr, 5 mL. All three times daily for up to fourteen days, then review.
Tab: Adults: In mild to moderate infections: 375 mg three times daily or 625 mg two times daily for up to fourteen days, then review. In severe infections: 625 mg three times daily or 1 gm two times daily.
INJECTION: Adults: 1.2 gm by IV inj or intermittent infusion eight or six hourly. Treat up to 14 days then review. Children: Up to 3 mth, 30 mg/kg every twelve hr in premature and full term infants during the perinatal period, increasing to eight hr thereafter; 3 mth-12 yr, 30 mg/kg eight or six hourly. All by IV inj or intermittent infusion for up to 14 days, then revise.

One of the following licensed pharmacy from the nearest location will deliver Clamoxin suspension DS 312.5 mg 60 mL. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “Clamoxin suspension DS 312.5 mg 60 mL”
Shopping Cart